0
0
2/7/23 at 8:48pm
Organization
Targetedonc.com
Author
Skye Montoya
32 words
0
Comments
New research of the BTK degrader NX-2127 shows promising results for breaking down resistance to the therapy in the lymphoma and leukemia settings.
You are the first to view
https://www.targetedonc.com/view/breaking-down-resistance-to-btk-inhibitors
Create an account
or login to join the discussion